Liyang Cui
- Biomaterials top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 11
-
- Photodynamic Therapy Research Studies 8
-
- Porphyrin and Phthalocyanine Chemistry 3
-
- Radiopharmaceutical Chemistry and Applications 7
- Monoclonal and Polyclonal Antibodies Research 3
-
- Peptidase Inhibition and Analysis 4
-
- Magneto-Optical Properties and Applications 3
-
- Cancer Research and Treatments 2
- Journals
- Advanced Healthcare Materials (3 papers)Molecular Pharmaceutics (2 papers)Journal of Lightwave Technology (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Liyang Cui
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Biomaterials 228
- Biomedical Engineering 671
- Pulmonary and Respiratory Medicine 241
- Materials Chemistry 270
- Radiology, Nuclear Medicine and Imaging 133
Countries citing papers authored by Liyang Cui
This map shows the geographic impact of Liyang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyang Cui more than expected).
Fields of papers citing papers by Liyang Cui
This network shows the impact of papers produced by Liyang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyang Cui. The network helps show where Liyang Cui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liyang Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2022 | 24 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 20 | |
| 6 | 2019 | 22 | |
| 7 | 2016 | 20 | |
| 8 | 2016 | 47 | |
| 9 | 2015 | 55 | |
| 10 | 2015 | 28 | |
| 11 | 2015 | 66 | |
| 12 | 2015 | 6 | |
| 13 | 2014 | 19 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 5 | |
| 16 | 2012 | 17 | |
| 17 | 2012 | 53 | |
| 18 | 2011 | 9 | |
| 19 | 2009 | 22 | |
| 20 | 2007 | 27 |
About Liyang Cui
Liyang Cui is a scholar working on Biophysics, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Biomedical Engineering and Oncology, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Peptidase Inhibition and Analysis (4 papers), Porphyrin and Phthalocyanine Chemistry (3 papers), Magneto-Optical Properties and Applications (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Biomaterials (228 citations), Biomedical Engineering (671 citations), Pulmonary and Respiratory Medicine (241 citations), Materials Chemistry (270 citations) and Radiology, Nuclear Medicine and Imaging (133 citations). Liyang Cui has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Gang Zheng, Juan Chen, Cheng Jin, Jianghong Rao, Fan Wang, Min Chen, Nidal Muhanna, Xianchuang Zheng, Guosheng Song and Zhuang Liu. Their work appears in journals such as Advanced Healthcare Materials, Molecular Pharmaceutics, Journal of Lightwave Technology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.